Clinical development of curcumin in neurodegenerative disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2015-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737175.2015.1044981PMID 26035622PMCID PMC6800094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurohormetic phytochemicals: An evolutionary-bioenergetic perspective.

  2015cited by this paper
• Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?

  2015cited by this paper
• Astrocyte Overexpression of Heme Oxygenase-1 Improves Outcome After Intracerebral Hemorrhage

  2015cited by this paper
• Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population

  2015cited by this paper
• Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice.

  2015cited by this paper
• O3‐13‐01: RETINAL AMYLOID FLUORESCENCE IMAGING PREDICTS CEREBRAL AMYLOID BURDEN AND ALZHEIMER'S DISEASE

  2014cited by this paper
• Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial

  2014cited by this paper
• Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway.

  2014cited by this paper
• Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice

  2013cited by this paper
• Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.

  2013cited by this paper
• A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

  2013cited by this paper
• Immunotherapy for Alzheimer's disease.

  2013cited by this paper
• Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment

  2012cited by this paper
• Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain.

  2012cited by this paper
• Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate*

  2012cited by this paper
• Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice*

  2012influential reference
• Nrf2-dependent Induction of Proteasome and Pa28αβ Regulator Are Required for Adaptation to Oxidative Stress*

  2012cited by this paper
• Risk factors of dementia in North India: a case–control study

  2012cited by this paper
• Effects of turmeric on Alzheimer's disease with behavioral and psychological symptoms of dementia

  2012cited by this paper
• Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

  2012cited by this paper
• Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

  2012cited by this paper
• Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine.

  2012cited by this paper
• Immunotherapy for Alzheimer’s disease

  2011cited by this paper
• Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease

  2011cited by this paper
• Towards a Pharmacophore for Amyloid

  2011cited by this paper
• Curcumin Attenuates Aluminum-Induced Oxidative Stress and Mitochondrial Dysfunction in Rat Brain

  2011cited by this paper
• Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice.

  2011cited by this paper
• Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies.

  2011cited by this paper
• Challenges associated with curcumin therapy in Alzheimer disease

  2011cited by this paper
• Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein*

  2010cited by this paper
• P4‐024: Degeneration of Mesencephalic Dopaminergic Neurons in Klotho Mouse Related to Vitamin D Signaling

  2010cited by this paper
• Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.

  2010cited by this paper
• Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron

  2010cited by this paper
• Curcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples

  2010cited by this paper
• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  2010cited by this paper
• Faculty Opinions recommendation of Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases.

  2010cited by this paper
• Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

  2010cited by this paper
• Enhanced Glutathione Efflux from Astrocytes in Culture by Low Extracellular Ca2+ and Curcumin

  2010cited by this paper
• PPARγ Agonist Curcumin Reduces the Amyloid-β-Stimulated Inflammatory Responses in Primary Astrocytes

  2010cited by this paper
• Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

  2010cited by this paper
• Why Pleiotropic Interventions are Needed for Alzheimer's Disease

  2010cited by this paper
• β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin

  2009influential reference
• Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.

  2009cited by this paper
• Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease

  2008cited by this paper
• Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects

  2008cited by this paper
• Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity

  2008cited by this paper
• A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin

  2008cited by this paper
• Curcumin inhibits aggregation of α-synuclein

  2008cited by this paper
• Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus*

  2008cited by this paper
• A broadly neuroprotective derivative of curcumin

  2008cited by this paper
• Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin.

  2008influential reference
• Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

  2008cited by this paper
• Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets.

  2007cited by this paper
• Curcumin: the Indian solid gold.

  2007cited by this paper
• Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model

  2007cited by this paper
• Curcumin effects on blood lipid profile in a 6-month human study.

  2007cited by this paper
• Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.

  2007cited by this paper
• Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets

  2007cited by this paper
• Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element.

  2007cited by this paper
• Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats.

  2007cited by this paper
• Neuroimaging and APOE Genotype: A Systematic Qualitative Review

  2007cited by this paper
• Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.

  2006cited by this paper
• Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients

  2006cited by this paper
• Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro

  2006cited by this paper
• Immunotherapy for Alzheimers disease

  2006cited by this paper
• Iron chelation in the biological activity of curcumin.

  2006cited by this paper
• Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition.

  2006cited by this paper
• Inhibition of homodimerization of Toll-like receptor 4 by curcumin.

  2006cited by this paper
• Curcumin Activates Defensive Genes and Protects Neurons Against Oxidative Stress

  2006cited by this paper
• Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

  2005cited by this paper
• A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model

  2005cited by this paper
• Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

  2005cited by this paper
• Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.

  2005cited by this paper
• Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid.

  2005cited by this paper
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo*

  2005cited by this paper
• Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

  2005cited by this paper
• Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

  2004cited by this paper
• Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase.

  2004cited by this paper
• Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models

  2004cited by this paper
• Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase

  2004cited by this paper
• NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models

  2004cited by this paper
• Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

  2004cited by this paper
• Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin

  2003cited by this paper
• Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype.

  2003cited by this paper
• Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element.

  2003cited by this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cited by this paper
• Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.

  2001cited by this paper
• Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.

  2001cited by this paper
• Incidence of Alzheimer’s disease in a rural community in India

  2001influential reference
• Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.

  2000cited by this paper
• The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells.

  1999cited by this paper
• Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes.

  1999cited by this paper
• Prevalence of Alzheimer's disease and other dementias in rural India

  1998influential reference
• In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties.

  1998cited by this paper
• Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

  1998cited by this paper
• Stability of curcumin in buffer solutions and characterization of its degradation products.

  1997cited by this paper
• Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.

  1997cited by this paper
• Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].

  1995cited by this paper

• Nutrigenomic influence of a curcumin-supplemented high glycemic diet on hippocampal microvasculature in male C57BL/6J mice.

  2026cites this paper
• Traditional to contemporary uses of the miraculous herb turmeric: a narrative review

  2025cites this paper
• ROLE OF DIETARY PHYTOPHARMACEUTICALS ACROSS THE GLOBE TO ALLEVIATE THE ALZHEIMER’S DISEASE: MECHANISM-BASED APPROACH

  2025cites this paper
• Neuroprotective Potential of Curcumin in Neurodegenerative Diseases: Clinical Insights Into Cellular and Molecular Signaling Pathways

  2025cites this paper
• Curcumin exerts neuroprotective effects on proliferation of neural stem cells in vitro and APP/PS1 mouse model in vivo

  2025cites this paper
• Harnessing Nature's Bounty: The Neuroprotective Potential of Phytoconstituents and Nanotechnology in Neurodegenerative Disease Therapeutics.

  2025cites this paper
• MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review

  2025cites this paper
• Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders

  2025cites this paper
• Le curcuma : des promesses et beaucoup de questions

  2025cites this paper
• Diet for the prevention and treatment of Parkinson’s disease

  2025cites this paper
• Molecular Dynamics and In Vitro Studies Elucidating the Tunable Features of Reconfigurable Nanodiscs for Guiding the Optimal Design of Curcumin Formulation

  2024cites this paper
• Curcumin- β-Cyclodextrin Molecular Inclusion Complex: A Water- Soluble Complex in Fast-dissolving Tablets for the Treatment of Neurodegenerative Disorders.

  2024cites this paper
• Exploring the Therapeutic Potential of Phytoconstituents for Addressing Neurodegenerative Disorders.

  2024cites this paper
• Neurotropic and immunomodulatory properties of a novel bioflavonoid composition

  2024cites this paper
• Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies

  2024cites this paper
• The Neuroprotective Potential of Polyphenols in Neurodegenerative Diseases

  2024cites this paper
• Curcumin and nano‐curcumin applications in psychiatric disorders

  2024cites this paper
• Identifying Turmeric Varieties (Curcuma spp.) Based on their Morphologies and Molecular Markers

  2024cites this paper
• Ameliorative Delivery of Docetaxel and Curcumin using PEG Decorated Lipomers: A Cutting-Edge In-Vitro/ In-Vivo Appraisal

  2024cites this paper
• Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review

  2024cites this paper
• Concentration-Dependent Effects of Curcumin on Membrane Permeability and Structure

  2024cites this paper
• JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review.

  2024cites this paper
• The Emerging Role of Curcumin in Inducing Neuronal Trans-differentiation of Mesenchymal Stem Cells: a Review

  2023cites this paper
• Neuroprotective Effects of Ecklonia cava in a Chronic Neuroinflammatory Disease Model

  2023cites this paper
• Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation.

  2023cites this paper
• Exploring Steroidal Surfactants as Potential Drug Carriers for an Anticancer Drug Curcumin: An Insight into the Effect of Surfactants' Structure on the Photophysical Properties, Stability, and Activity of Curcumin.

  2023cites this paper
• Amendment of Altered Immune Response by Curcumin in Drosophila Model of Huntington’s Disease

  2023cites this paper
• Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson’s and Alzheimer’s Disease

  2023cites this paper
• Curcumin-Loaded nano-phospholipid complex maintains mitochondrial homeostasis through regulation of parkin in Parkinson’s disease

  2023cites this paper
• Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?

  2023cites this paper
• Curcumin ameliorates traumatic brain injury via C1ql3-mediated microglia M2 polarization

  2023cites this paper
• Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases

  2023cites this paper
• Homeostasis and dyshomeostasis of the retina

  2023cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens

  2022cites this paper
• The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature

  2022cites this paper
• Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein

  2022cites this paper
• Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology

  2022cites this paper
• Tetrahydrocurcumin Ameliorates Acute Hypobaric Hypoxia-Induced Cognitive Impairment in Mice

  2022cites this paper
• Nucleus-Targeted Nanoparticles Induce Autophagy of Vascular Endothelial Cells in Cervical Spondylosis of Vertebral Artery Type Through PI3K/Akt/mTOR Signaling Pathway.

  2022cites this paper
• Combined drug triads for synergic neuroprotection in retinal degeneration.

  2022cites this paper
• Phytochemical Investigation, Synthesis and Characterization of Iron Oxide Nanoparticles by Peel Extract of Punica Granatum

  2022cites this paper
• Antineoplastic Effects of Curcumin Against Colorectal Cancer: Application and Mechanisms

  2022cites this paper
• Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Possible Therapeutic Role of Curcumin

  2022cites this paper
• Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis

  2021cites this paper
• Dichloroacetic acid-induced dysfunction in rat hippocampus and the protective effect of curcumin

  2021cites this paper
• The Role of Curcumin in Post-Ischemic Brain

  2021cites this paper
• Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM2 Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report

  2021cites this paper
• 1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents

  2021cites this paper
• Selective modified stripping voltammetric sensor based on Ce-1,4-benzenedicarboxylic metal–organic frameworks porous nanoparticles for picomolar detection of curcumin

  2021cites this paper
• Diagnosis and Treatment of Alzheimer’s Disease:

  2021cites this paper
• Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges

  2021cites this paper
• Immunotherapeutics for AD: A Work in Progress.

  2021cites this paper
• Can essential oils be allelopathic to Lolium multiforum without harming Solanum lycopersicum?

  2021cites this paper
• Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer’s Disease and Its Neuropsychiatric Symptoms

  2021cites this paper
• Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease

  2021cites this paper
• Polyphenols and neurodegenerative diseases: focus on neuronal regeneration

  2021cites this paper
• Curcumin loaded drug delivery systems in Parkinson’s disease

  2021cites this paper
• Effects of time and temperature variations on curcumin contents and antioxidant activity of tamarind-turmeric herbs

  2021cites this paper
• The Golden Spice Turmeric (Curcuma longa) and Its Feasible Benefits in Prospering Human Health—A Review

  2021cites this paper
• Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease

  2021cites this paper
• Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.

  2021cites this paper
• A Novel Chemical Profile of a Selective In Vitro Cholinergic Essential Oil from Clinopodium taxifolium (Kunth) Govaerts (Lamiaceae), a Native Andean Species of Ecuador

  2020cites this paper
• Targeting the NLRP3 inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders.

  2020cites this paper
• Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia

  2020cites this paper
• Sekundäre Neuroprotektion beim Glaukom durch ergänzende medikamentöse Therapiekonzepte

  2020influential citation
• Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

  2020cites this paper
• Curcumin: A Review for Health Benefits

  2020cites this paper
• Effects of Curcumin on Lipid Membranes: an EPR Spin-label Study

  2020cites this paper
• Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

  2020cites this paper
• Combination use of tolfenamic acid with curcumin improves anti-inflammatory activity and reduces toxicity in mice.

  2020cites this paper
• Multiple-component dual-phase solid lipid nanoparticles with conjugated transferrin for formulating antioxidants and nerve growth factor against neuronal apoptosis

  2020cites this paper
• Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases

  2020cites this paper
• Effects of curcumin on neurological diseases: focus on astrocytes

  2020cites this paper
• Natural-based consumer health nanoproducts: medicines, cosmetics, and food supplements

  2020cites this paper
• Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk

  2020cites this paper
• Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect

  2020cites this paper
• Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APPswe/PS1ΔE9 transgenic mice for the diagnosis of Alzheimer's disease.

  2020cites this paper
• Neuroprotective Medicinal Plants: Focus on Curcuma longa

  2020cites this paper
• Modulating disease-relevant tau oligomeric strains by small molecules

  2020cites this paper
• Aquilariae Lignum Methylene Chloride Fraction Attenuates IL-1β-Driven Neuroinflammation in BV2 Microglial Cells

  2020cites this paper
• Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways

  2020influential citation
• A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden.

  2020cites this paper
• Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice

  2020cites this paper
• The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols

  2020cites this paper
• Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea.

  2020cites this paper
• Evaluation of curcumin assistance in the antimicrobial and photocatalytic activity of a carbon based TiO2nanocomposite

  2020cites this paper
• Therapeutic Potential of Nutraceuticals to Protect Brain after Stroke.

  2020cites this paper
• Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington’s Disease

  2020cites this paper
• Cognitive decline prevention in offspring of Pb+2 exposed mice by maternal aerobic training and Cur/CaCO3@Cur supplementations: In vitro and in vivo studies.

  2020cites this paper
• Inhibitory Effect of Hexahydrocurcumin on Memory Impairment and Amyloidogenesis in Dexamethasone-Treated Mice

  2020cites this paper
• Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s disease

  2020cites this paper
• Curcumin in Neurological Disorders

  2019cites this paper
• Curcumin Protects Human Umbilical Vein Endothelial Cells against H2O2-Induced Cell Injury

  2019cites this paper
• Medicinal Uses of Curcumin : Anti-diabetic Activity : Curcumin

  2019cites this paper
• Curcumin Impact on Multiple Sclerosis

  2019cites this paper
• Benefits of curcumin in brain disorders

  2019cites this paper
• Significance of Antioxidants in the Treatment and Prevention of Neurodegenerative Diseases

  2019cites this paper
• Effects of Curcumin on Vessel Formation Insight into the Pro- and Antiangiogenesis of Curcumin

  2019cites this paper
• Monocarbonyl Curcumin-Based Molecular Hybrids as Potent Antibacterial Agents

  2019cites this paper